The tyrosine phosphatase Shp2 is a potential target for the treatment of obesity and has a crucial role in glucose and lipid metabolism, and the development of adipose tissues.19–21 However, the regulatory effect of Shp2 on these processes is unclear. This evidence concerns the gene PTPN11 and obesity due to melanocortin 4 receptor deficiency.